(Q46594525)

23 December 2017

title

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases (English)

1 reference

23 December 2017

0 references

6

1 reference

23 December 2017

author name string

Stephen S Koh

1

1 reference

23 December 2017

Jia-Perng J Wei

2

1 reference

23 December 2017

Xinmin Li

3

1 reference

23 December 2017

Rong R Huang

4

1 reference

23 December 2017

Ngan B Doan

5

1 reference

23 December 2017

Alistair J Cochran

7

1 reference

23 December 2017

Scott W Binder

8

1 reference

23 December 2017

publication date

9 March 2012

1 reference

23 December 2017

published in

Modern Pathology

1 reference

23 December 2017

volume

25

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

828-837

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.32

exact match

0 references

cites work

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Sentinel-node biopsy or nodal observation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Microarray analysis and tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression profiling of melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Novel genes associated with malignant melanoma but not benign melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

The gene expression signatures of melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

A gene expression signature associated with survival in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

21 January 2018

Maspin: the new frontier

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

Biological functions of melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Osteopontin as a molecular prognostic marker for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.32

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2012.32

1 reference

23 December 2017

PubMed ID

22411186

1 reference

23 December 2017